Microscopically positive margins for primary gastrointestinal stromal tumors: Analysis of risk factors and tumor recurrence.
Journal of the American College of Surgeons.
Times cited: 59
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Times cited: 802